[1] R. K. Tulebaev, Sh. B. Sadykov, V. A. Romanov, G. Kh. Khalitova, “Indicators of the activity of the immune system during laser therapy of vasomotor rhinitis,” Vestn. Otorinolaringol. 1, 46–49 (1989).

[2] B. V. Shevrygin, S. V. Rybalkin, F. F. Pekli, L. V. Feniksova, “Correction of microcirculatory disorders with low-energy laser radiation in children with vasomotor rhinitis,” Vestn. Otorinolaringol. 2, 31–33 (2000).

[3] I. Kruchinina, L. V. Feniksova, S. V. Rybalkin, F. F. Pekli, “Therapeutic effect of helium-neon laser on microcirculation of nasal mucosa in children with acute and chronic maxillary sinusitis as measured by conjunctival biomicroscopy,” Vestn. Otorinolaringol. 3, 26–30 (1991).

[4] C. Y. Liu, P. Zhu, Intranasal Low Intensity Laser Therapy, People’s Military Medical Press, Beijing, pp. 51–354 (2009).

[5] W. J. Su, Y. W. Zhang, Y. Shi, A. H. Liu, L. L. Zhang, Z. Y. Qian, T. C. Y. Liu, “Clinic report of intranasal low intensity laser therapy on vascular diseases,” Lasers Surg. Med. 41(21S), 67–67 (2009).

[6] C. Xu, L. Wang, J. Liu, Y. Tan, Q. Li, “Endonasal low energy He-Ne laser treatment of insomnia,” Qian Wei. J. Med. Pharm. 18(5), 337–338 (2001).

[7] C. Xu, L. Wang, X. Shang, Q. Li, “The treatment of Alzheimer’s disease with hypoenergy He-Ne laser,” Prac. J. Med. Pharm. 19(9), 647–648 (2002).

[8] C. Xu, L. Wang, C. Lu, “Endonasal low energy He– Ne laser treatment of poststroke depression,” Prac. J. Med. Pharm. 19(11), 893 (2002).

[9] C. Xu, C. Lu, L. Wang, Q. Li, “The effects of endonasal low energy He-Ne laser therapy on antioxydation of Parkinson’s disease,” Prac. J. Med. Pharm. 20(11), 816–817 (2003).

[10] H. M. Chang, U. I. Wu, C. T. Lan, “Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats,” J. Pineal Res. 47(3), 211–220 (2009).

[11] M. Bubis, N. Zisapel, “A role for NAD+ and cADPribose in melatonin signal transduction,” Mol. Cell Endocrinol. 137(1), 59–67 (1998).

[12] M. Tajes, J. Gutierrez-Cuesta, D. Ortu no-Sahagun, A. Camins, M. Pall`as, “Anti-aging properties of melatonin in an in vitro murine senescence model: Involvement of the sirtuin 1 pathway,” J. Pineal Res. 47(3), 228–237 (2009).

[13] T. Finkel, C. X. Deng, R. Mostoslavsky, “Recent progress in the biology and physiology of sirtuins,” Nature 460(7255), 587–591 (2009).

[14] L. Zeng, R. Chen, F. Liang, H. Tsuchiya, H. Murai, T. Nakahashi, K. Iwai, T. Takahashi, T. Kanda, S. Morimoto, “Silent information regulator, sirtuin 1, and age-related diseases,” Geriatr. Gerontol. Int. 9(1), 7–15 (2009).

[15] Y. Nakahata, S. Sahar, G. Astarita, M. Kaluzova, P. Sassone-Corsi, “Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1,” Science 324(5927), 598–599 (2009).

[16] T. Karu, The Science of Low-Power Laser Therapy, Gordon and Breach Science Publishers, Amsterdam, pp. 95–121 (1998).

[17] C. Y. Liu, F. H. Li, L. Zhu, “Sirtuins-mediated mechanism of optical rehabilitation of animal nonvision cells,” Chin. J. Laser. 36(10), 2485–2492 (2009) (in Chinese).

[18] S. Bruzzone, L. Guida, E. Zocchi, L. Franco, A. De Flora, “Connexin 43 hemi channels mediate Ca2+- regulated transmembrane NAD+ fluxes in intact cells,” FASEB J. 15(1), 10–12 (2001).

[19] K. T. Howitz, K. J. Bitterman, H. Y. Cohen, D. W. Lamming, S. Lavu, J. G. Wood, R. E. Zipkin, P. Chung, A. Kisielewski, L. L. Zhang, B. Scherer, D. A. Sinclair, “Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan,” Nature 425(6954), 191–196 (2003).

[20] V. C. de Boer, M. C. de Goffau, I. C. Arts, P. C. Hollman, J. Keijer, “SIRT1 stimulation by polyphenols is affected by their stability and metabolism,” Mech. Ageing Dev. 127(7), 618–627 (2006).

[21] S. Bermon, “Airway inflammation and upper respiratory tract infection in athletes: Is there a link ” Exerc. Immunol. Rev. 13, 6–14 (2007).

[22] J. M. Davis, E. A. Murphy, M. D. Carmichael, B. Davis, “Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance,” Am. J. Physiol. Regul. Integr. Comp. Physiol. 296(4), R1071–R1077 (2009).

[23] D.C.Nieman, D. A. Henson, S. J.Gross,D. P. Jenkins, J. M. Davis, E. A. Murphy, M. D. Carmichael, C. L. Dumke, A. C. Utter, S. R. McAnulty, L. S. McAnulty, E. P. Mayer, “Quercetin reduces illness but not immune perturbations after intensive exercise,” Med. Sci. Sports Exerc. 39(9), 1561–1569 (2007).

[24] J. M. Davis, E. A. Murphy, J. L. McClellan, M. D. Carmichael, J. D. Gangemi, “Quercetin reduces susceptibility to influenza infection following stressful exercise,” Am. J. Physiol. Regul. Integr. Comp. Physiol. 295(2), R505–R509 (2008).

[25] S. Rajendrasozhan, S. R. Yang, V. L. Kinnula, I. Rahman, “SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease,” Am. J. Respir. Crit. Care Med. 177(8), 861–870 (2008).

[26] Q. Chen, J. Ding, H. Long, F. Yang, J. Gong, “He- Ne laser therapy on child chronic cough and postnasal drip,” Guangdong Med. J. 26(10), 1377–1378 (2005).

[27] J. B. Langdeau, L. P. Boulet, “Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes,” Sports Med. 31(8), 601–616 (2001).

[28] B. Kos-Kudla, “Iatrogenic adrenal cortex failure in patients with steroid dependent asthma in relation to different methods of glucocorticoid treatment,” Endocr. Regul. 32(2), 99–106 (1998).

[29] M. Lee, S. Kim, O. K. Kwon, S. R. Oh, H. K. Lee, K. Ahn, “Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma,” Int. Immunopharmacol. 9(4), 418–424 (2009).

[30] K. Ito, K. F. Chung, I. M. Adcock, “Update on glucocorticoid action and resistance,” J. Allergy Clin. Immunol. 117(3), 522–543 (2006).

[31] H. J. Park, C. M. Lee, I. D. Jung, J. S. Lee, Y. I. Jeong, J. H. Chang, S. H. Chun, M. J. Kim, I. W. Choi, S. C. Ahn, Y. K. Shin, S. R. Yeom, Y. M. Park, “Quercetin regulates Th1/Th2 balance in a murine model of asthma,” Int. Immunopharmacol. 9(3), 261–267 (2009).

[32] N. S. Ostronosova, “Low-intensity laser radiation in therapy of bronchial asthma,” Vopr Kurortol Fizioter Lech Fiz Kult. 2, 8–10 (2006).

[33] U. R. Farkhutdinov, “Intravascular laser irradiation of blood in the treatment of patients with bronchial asthma,” Ter. Arkh. 79(3), 44–48 (2007).

[34] A. Liu, Y. Jiang, “The therapeutic effect and mechanism of low-energy intravascular He-Ne laser irradiation on bronchial asthma,” J. Chin. Micro. 4(1), 42–44 (2000).

[35] U. M. Kujala, P. Marti, J. Kaprio, M. Hernelahti, en H. Tikkan, S. Sarna, “Occurrence of chronic disease in former top-level athletes. Predominance of benefits, risks or selection effects ” Sports Med. 33(8), 553–561 (2003).

[36] F. Peris, E. Mart′ nez, X. Badia, M. Brosa, “Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs,” Pharmacoeconomics. 19(7), 779–790 (2001).

[37] W. B. Jonas, C. P. Rapoza, W. F. Blair, “The effect of niacinamide on osteoarthritis: A pilot study,” Inflamm. Res. 45(7), 330–334 (1996).

[38] L. H. Li, L. J. Wu, S. I. Tashiro, S. Onodera, F. Uchiumi, T. Ikejima, “Activation of the SIRT1 pathway and modulation of the cell cycle were involved in silymarin’s protection against UV-induced A375- S2 cell apoptosis,” J. Asian Nat. Prod. Res. 9(3–5), 245–252 (2007).

[39] S. A. Hussain, N. A. Jassim, I. T. Numan, Al-I. I. Khalifa, T. A. Abdullah, “Anti-inflammatory activity of silymarin in patients with knee osteoarthritis: A comparative study with piroxicam and meloxicam,” Saudi. Med. J. 30(1), 98–103 (2009).

[40] B. Hegedus, L. Viharos, M. Gervain, M. G′alfi, “The effect of low-level laser in knee osteoarthritis: A double-blind, randomized, placebo-controlled trial,” Photomed. Laser Surg. 27(4), 577–584 (2009).

[41] X. L. Xiao, X. P. Liang, X. C. Xiao, X. P. Hong, “Rehabilitation effect of intravascular laser irradiation on blood on the elderly patients with osteoarthritis,” Chin. J. Clin. Rehabil. 6(16), 2432– 2433 (2002).

[42] K. Cheung, P. Hume, L. Maxwell, “Delayed onset muscle soreness: Treatment strategies and performance factors”, Sports Med. 33(2), 145–164 (2003).

[43] T. C. Y. Liu, P. Huang, X. G. Liu, X. Y. Chen, J. Liu, S. X. Wang, L. P. Cui, X. Y. Xu, H. Guo, H. Jin, S. X. Deng, L. L. Ji, “Delayed onset muscle soreness: Three-phase hypothesis and its clinical applications,” Med. Sci. Sport Exer. 38(5) Supplement, S124–S125 (2006).

[44] Z. E. Floyd, Z. Q. Wang, G. Kilroy, W. T. Cefalu, “Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol,” Metabolism 57(7 Suppl 1), S32–S38 (2008).

[45] A. N. Kavazis, K. C. DeRuisseau, J.M.McClung,M. A. Whidden, D. J. Falk, A. J. Smuder, T. Sugiura, S. K. Powers, “Diaphragmatic proteasome function is maintained in the ageing Fisher 344 rat,” Exp. Physiol. 92(5), 895–901 (2007).

[46] F. Li, L. Zhang, J. Craddock, A. J. Bruce Keller, K. Dasuri, A. Nguyen, J. N. Keller, “Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heart,” Mech. Ageing Dev. 129(9), 515–521 (2009).

[47] G. A. Benavides, G. L. Squadrito, R. W. Mills, H. D. Patel, T. S. Isbell, R. P. Patel, V. M. Darley- Usmar, J. E. Doeller, D. W. Kraus, “Hydrogen sulfide mediates the vasoactivity of garlic,” Proc. Natl. Acad. Sci. USA 104(46), 17977–17982 (2007).

[48] D. L. Miller, M. B. Roth, “Hydrogen sulfide increases thermotolerance and lifespan in caenorhabditis elegans,” Proc. Natl. Acad. Sci. USA 104(51), 20618–20622 (2007).

[49] Q. S. Su, Y. Tian, J. G. Zhang, H. Zhang, “Effects of allicin supplementation on plasma markers of exercise-induced muscle damage, IL-6 and antioxidant capacity,” Eur. J. Appl. Physiol. 103(3), 275– 283 (2008).

[50] P. Thomas, Y. J. Wang, J. H. Zhong, S. Kosaraju, N. J. O’Callaghan, X. F. Zhou, M. Fenech, “Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer’s disease,” Mutat. Res. 661(1–2), 25–34 (2009).

[51] J. M. Davis, E. A. Murphy, M. D. Carmichael, M. R. Zielinski, C. M. Groschwitz, A. S. Brown, J. D. Gangemi, A. Ghaffar, E. P. Mayer, “Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage,” Am. J. Physiol. Regul. Integr. Comp. Physiol. 292(6), R2168–R2173 (2007).

[52] X. G. Liu, “Therapeutic effects of low intensity laser irradiation on exercise-induced muscle damage and its mechanism,” Huazhong University of Science and Technology, PhD Thesis. (2009).

[53] C. K. Sen, S. Khanna, G. Gordillo, D. Bagchi, M. Bagchi, S. Roy, “Oxygen, oxidants, and antioxidants in wound healing: An emerging paradigm,” Ann. NY Acad. Sci. 957, 239–249 (2002).

[54] M. S. Goldenberg, “Wound care management: Proper protocol differs from athletic trainers’ perceptions,” J. Athl. Train. 31(1), 12–16 (1996).

[55] G. Soybir, C. Topuzlu, O. Odaba s, K. Dolay, A. Bilir, F. K¨oksoy, “The effects of melatonin on angiogenesis and wound healing,” Surg. Today 33(12), 896–901 (2003).

[56] J. T. Hopkins, T. A. McLoda, J. G. Seegmiller, G. David Baxter, “Low-level laser therapy facilitates superficial wound healing in humans: A triple-blind, sham-controlled study,” J. Athl. Train. 39(3), 223– 229 (2004).

[57] N. R. Kravchenko-Berezhnaia, V. V. Moroz, V. L. Kozhura, “Laser radiation to correct disorders of blood albumin transport in severe mechanical trauma,” Anesteziol. Reanimatol. 6, 22–24 (2002).

[58] Q. Luo, M. G. Xiong, H. Gu, J. H. Wang, “Effect of intravascular low level laser irradiation used in avulsion injury,” Chin. J. Rep. Reconstr. Surg. 14(1), 7–9 (2000).

[59] E. Sch¨ultke, H. Kamencic, M. Zhao, G. F. Tian, A. J. Baker, R. W. Griebel, B. H. Juurlink, “Neuroprotection following fluid percussion brain trauma: A pilot study using quercetin,” J. Neurotrauma. 22(12), 1475–1484 (2005).

[60] T. Wang, J. Gu, P. F. Wu, F. Wang, Z. Xiong, Y. J. Yang, W. N. Wu, L. D. Dong, J. G. Chen, “Protection by tetrahydroxystilbene glucoside against cerebral ischemia: Involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation,” Free Radic. Biol. Med. 47(3), 229–240 (2009).

[61] S. Sharma, Y. Zhuang, Z. Ying, A. Wu, F. Gomez- Pinilla, “Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma,” Neuroscience 161(4), 1037–1044 (2009).

[62] C. M′esenge, I. Margaill, C. Verrecchia, M. Allix, R. G. Boulu, M. Plotkine, “Protective effect of melatonin in a model of traumatic brain injury in mice,” J. Pineal Res. 25(1), 41–46 (1998).

[63] A. Oron, U. Oron, J. Streeter, L. de Taboada, A. Alexandrovich, V. Trembovler, E. Shohami, “Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits,” J. Neurotrauma. 24(4), 651–656 (2007).

[64] N. H. Golden, “A review of the female athlete triad (amenorrhea, osteoporosis and disordered eating),” Int. J. Adolesc. Med. Health. 14(1), 9–17 (2002).

[65] M. Mori, T. Aizawa, M. Tokoro, T. Miki, Y. Yamori, “Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle-aged Japanese women,” Clin. Exp. Pharmacol. Physiol. 31 (Suppl 2), S39– S41 (2004).

[66] S. Uslu, A. Uysal, G. Oktem, M. Yurtseven, T. Tanyal cin, G. Ba sdemir, “Constructive effect of exogenous melatonin against osteoporosis after ovariectomy in rats,” Anal. Quant. Cytol. Histol. 29(5), 317–325 (2007).

[67] S. Khosla, J. J.Westendorf, M. J. Oursler, “Building bone to reverse osteoporosis and repair fractures,” J. Clin. Invest. 118(2), 421–428 (2008).

[68] C. M. B¨ackesj¨o, Y. Li, U. Lindgren, L. A. Haldos′en, “Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells,” Cells Tissues Organs 189(1–4), 93–97 (2009).

[69] M. Xu, T. Deng, F. Mo, B. Deng, W. Lam, P. Deng, X. Zhang, S. Liu, “Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells,” Photomed. Laser Surg. 27(2), 309–315 (2009).

[70] R. J. Garten, C. T. Davis, C. A. Russell, B. Shu, S. Lindstrom, A. Balish, W. M. Sessions, X. Xu, E. Skepner, V. Deyde, M. Okomo-Adhiambo, L. Gubareva, J. Barnes, C. B. Smith, S. L. Emery, M. J. Hillman, P. Rivailler, J. Smagala, M. de Graaf, D. F. Burke, R. A. Fouchier, C. Pappas, C. M. Alpuche-Aranda, H. L′opez-Gatell, H. Olivera, I. L′opez, C. A. Myers, D. Faix, P. J. Blair, C. Yu, K. M. Keene,P. D. Dotson, Jr., D. Boxrud, A. R. Sambol, S. H. Abid, K. St George, T. Bannerman, A. L. Moore, D. J. Stringer, P. Blevins, G. J. Demmler-Harrison, M. Ginsberg, P. Kriner, S. Waterman, S. Smole, H. F. Guevara, E. A. Belongia, P. A. Clark, S. T. Beatrice, R. Donis, J. Katz, L. Finelli, C. B. Bridges, M. Shaw, D. B. Jernigan, T. M. Uyeki, D. J. Smith, A. I. Klimov, N. J. Cox, “Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans,” Science 325(5937), 197–201 (2009).

[71] G. J. Maestroni, “Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer,” Adv. Exp. Med. Biol. 467, 217–226 (1999).

[72] J. Dudley, S. Das, S. Mukherjee, D. K. Das, “Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose,” J. Nutr. Biochem. 20(6), 443–452 (2009).

[73] I. Adriaens, P. Jacquet, R. Cortvrindt, K. Janssen, J. Smitz, “Melatonin has dose-dependent effects on folliculogenesis, oocyte maturation capacity and steroidogenesis,” Toxicology 228(2–3), 333–343 (2006).

[74] P. Queneau, P. Grandmottet, “Prevention of avoidable iatrogenic effects: The obligation for vigilance,” Presse Med. 27(25), 1280–1282 (1998).